| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.092 | 0.2 |